Tuberculosis in the begining of the XXI century;La tuberculosis en los albores del siglo XXI

Revista Espanola de Salud Publica

Volumn 77, Issue 2, 2003, Pages 183-187

  Diez Ruiz Navarro, Mercedes ^a  

^a CARLOS III INSTITUTE OF HEALTH   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

EDITORIAL; EVALUATION; GOVERNMENT; HEALTH PROGRAM; HUMAN IMMUNODEFICIENCY VIRUS; MEDICAL INFORMATION SYSTEM; TUBERCULOSIS; VIRUS DETECTION; WORLD HEALTH ORGANIZATION;

ADULT; ANTITUBERCULAR AGENTS; CLINICAL TRIALS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; EUROPE; EUROPEAN UNION; FEMALE; HIV INFECTIONS; HUMANS; MALE; SPAIN; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

EID: 0037352202     PISSN: 11355727     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (15)

1. TB. A Global Emergency. WHO Report on the TB Epidemic. WHO/TB/94.177.
2. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Dye C. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Inter Med 2003 (en prensa).
3. Raviglione MC, Pio A. Evolution of WHO policies for tuberculosis control, 1948-2001. Lancet 2002;359:775-80.
4. EuroTB (InVS/KNCV) and the national coordinators for tuberculosis surveillance in the WHO European Region. Surveillance of tuberculosis in Europe. Report on tuberculosis cases notified in 1999. March 2002.
5. Rieder H, Watson J, Raviglione M et al. Recommendations of a Working Group of the World Health Organisation (WHO) and the Europe Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting on tuberculosis cases. Surveillance of tuberculosis in Europe. Eur Resp J 1996;9:1097-104.
6. Veen J, Raviglione M, Rieder HL, Migliori GB, Graf P, Grzemska, Zalesky R. Standardised Tuberculosis Treatment Outcome Monitoring in Europe-Recomendations of a Working Group of the World Health Organization and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting by cohort analysis of treatment outcome in tuberculosis patients. Eur Respir J 1998;12:505-510.
7. Schwoebel V, Lambregts-van Weezenbeek, Moro ML; Drobniesky F, Hoffner S, Raviglione MC et al. Surveillance of anti-tuberculosis drug resistance in Europe. Recommendations od a World Health Organization (WHO) and IUATLD Working Group for standardisation. Eur Resp J 2000; 16:364-71.
8. Broekmans JF, Migliori GB, Rieder HL, Leese J, Ruutu P, Loddenkemper R, Raviglione M. European framework for effective tuberculosis control and elimination in countries with a low incidence of tuberculosis. Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and KNCV (Royal Netherlands Tuberculosis Association) Working Group. Eur Resp J 2002;19:765-75.
9. Rodríguez Valín E. Situación actual de la tuberculosis en España: Incidencia y mortalidad desde 1995. Características de los casos de tuberculosis y meningitis tuberculosa declarados en 2000. Bol Epidemiol Sem 2001;9:293-6.
10. Grupo de trabajo del PMIT. La tuberculosis en España: resultados del Proyecto Multicéntrico de Investigación sobre Tuberculosis (PMIT). Madrid: Instituto de Salud Carlos III; 1999.
11. Centro Nacional de Epidemiología. Definiciones de caso y formularios de notificación al nivel central de las enfermedades de declaración obligatoria. Madrid: Ministerio de Sanidad y Consumo; 1996.
12. Samper S, Iglesias MJ and Tello O on behalf of the Spanish Working Group on MDR-TB. The Spanish multidrug resistant tuberculosis network. Eurosurveillance 2000;5:43-5.
13. Anti-tuberculosis drug resistance in the world. Report No. 2 Prevalence and Trends. The WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance. Geneve: WHO;2000.
14. Díaz A, Diez M, Bleda MJ por el Grupo de Trabajo de ResTB. Problemas en la selección de una muestra adecuada para estudiar la prevalencia de resistencias a fármacos antituberculosos. Gac Sanit 2002;16(Supl 1):111.
15. Díez Ruiz-Navarro M, Hernández Espinosa JA, Caloto González T, Castells Carrillo C, Domínguez García A, García Fulgueiras AM, Gayoso Diz P, López de Valdivielso MJ, Vázquez Fernández MF por el Grupo de Trabajo del PMIT-2. Resultados del tratamiento antituberculoso en seis Comunidades Autónomas españolas. Med Clin (Barc) 2001;117:574-80.